IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000062 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 15, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
86,562
Total Value
$674,621.55
P&L
+inf% (+$2,518,370.25)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 21,055 | $0.00 | $0.00 | 103,734 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Common Stock | โ | Jan 16, 2026 | Sale | 8,977 | $75.15 | $674,621.55 | 94,757 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Performance Restricted Stock Units | Derivative | Jan 15, 2026 | Grant/Award | 25,800 | $0.00 | $0.00 | 89,282 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Restricted Stock Unit | Derivative | Jan 15, 2026 | Exercise/Conversion | 21,055 | $0.00 | $0.00 | 17,434 | Direct | โ | View Details | |
EVP, Chief Scientific Officer | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 9,675 | $0.00 | $0.00 | 27,109 | Direct | โ | View Details |